MyoFuse is a fully Al-based workflow for automated quantification of skeletal muscle cell fusion in vitro
Revolutionizing Myoblast Fusion Quantification with AI: MyoFuse Delivers Unbiased, High-Throughput Analysis
MyoFuse presents a groundbreaking AI-based workflow for accurately quantifying skeletal muscle cell fusion (Fusion Index, FI) in vitro. This innovation addresses critical limitations of traditional manual and existing automated methods, which often suffer from tediousness, human bias, and misidentification of nuclei, leading to FI overestimation.
The workflow leverages Cellpose for precise nucleus segmentation, even within dense clusters, and employs a custom convolutional neural network (trained with Svetlana) for classifying myonuclei based on cytoplasmic staining rather than simple spatial overlay. This approach is superior because it accurately distinguishes myotube nuclei from myoblast nuclei located above or below myotubes, a common source of error.
Validated across mouse C2C12 and human primary myotubes, MyoFuse demonstrates high accuracy (0.954 and 0.911 respectively for classification, r > 0.99 for FI correlation with expert annotation) and robust performance. By processing large images, it minimizes selection bias and accounts for cellular heterogeneity, making it a reliable, high-throughput solution for muscle cell research.
MyoFuse is available as a Python notebook, offering a user-friendly graphical interface and distributed under an MIT License. It marks a significant advancement in automated image analysis for skeletal muscle differentiation studies, promising enhanced data reliability and reproducibility in a research context.
Executive Impact: Key Performance Indicators
MyoFuse significantly enhances the accuracy and efficiency of skeletal muscle cell fusion analysis, delivering quantifiable improvements over traditional methods. These metrics highlight the robust performance and reliability of the AI-driven workflow.
r=0.991
FI Correlation (C2C12)
r=0.937
FI Correlation (Human)
0.954
Classification Accuracy (C2C12)
0.911
Classification Accuracy (Human)
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Technical Innovation
MyoFuse introduces a novel AI-based workflow that combines Cellpose for nucleus segmentation and a custom convolutional neural network for myonuclei classification. Unlike previous methods, it relies on local loss of MyHC fluorescence for classification, effectively distinguishing true myonuclei from overlying/underlying myoblasts, and avoids fluorescence intensity thresholding.
MyoFuse AI Workflow Overview
Nucleus-specific & Myotube-specific Staining (MyHC, Hoechst)
→
Cellpose-based Nuclei Segmentation
→
MyHC Fluorescence Normalization
→
Svetlana-trained Neural Network Classification
→
Myonuclei (In) / Myoblast Nuclei (Out) Determination
→
Fusion Index Calculation
AUC=0.988
C2C12 Myonuclei AUC (Area Under the Curve)
AUC=0.975
Human Primary Myonuclei AUC (Area Under the Curve)
Addressing Limitations
MyoFuse directly addresses the biases and inaccuracies inherent in manual and existing automated methods. By employing sophisticated neural networks, it achieves reliable segmentation of clustered nuclei and overcomes the issue of misclassifying myoblast nuclei located near myotubes, which previously led to FI overestimation.
| Feature | Traditional Mask Method | MyoFuse AI Workflow |
|---|---|---|
| Nuclei Segmentation | Indirect estimation in clusters |
|
| Classification Logic | Spatial overlay (prone to error) |
|
| Selection Bias | High, due to small imaging areas |
|
| Threshold Dependency | High, prone to variability |
|
| FI Overestimation | Common |
|
| Throughput | Moderate |
|
Validation & Robustness
The workflow was rigorously validated against expert manual annotations, demonstrating strong correlations and high accuracy in both mouse C2C12 and human primary myotubes, including those from morphologically distinct muscles not used in training (vastus lateralis). This broad validation underscores its robustness and generalizability.
Accuracy=0.944
Vastus Lateralis Myonuclei Classification Accuracy
Impact of Selection Bias on FI Quantification
The study analyzed a large image partitioned into tiles to demonstrate how random selection of smaller zones can lead to significant variability and bias in Fusion Index (FI) quantification. MyoFuse's ability to process large, comprehensive images significantly reduces this selection bias, ensuring more accurate and reproducible results across heterogeneous cell cultures. This highlights the value of high-throughput AI in achieving reliable biological insights.
Key Takeaway: Large-scale image processing by MyoFuse mitigates selection bias and accounts for heterogeneity in myotube density, leading to more reliable FI quantification.
Advanced ROI Calculator: MyoFuse Implementation
Estimate the potential time savings and cost efficiencies your lab could achieve by automating skeletal muscle cell fusion index (FI) quantification with MyoFuse.
Annual Cost Savings
$0
Annual Hours Reclaimed
0
MyoFuse Implementation Roadmap
Our structured roadmap ensures a smooth transition to an AI-powered workflow, maximizing your research efficiency and accuracy in skeletal muscle cell fusion analysis.
Phase 1: Setup & Initial Data Acquisition (Weeks 1-2)
Installation of MyoFuse Python notebook and required dependencies. Initial image acquisition using existing microscopy setups and standard immunofluorescence protocols (MyHC, Hoechst). Collection of a small validation dataset for initial testing.
Phase 2: Model Adaptation & Local Validation (Weeks 3-4)
Retraining the Cellpose model and the classification neural network with a small subset of your specific cell type images if necessary (using Svetlana Napari plugin). Local validation against expert manual annotations to ensure optimal performance for your experimental conditions.
Phase 3: High-Throughput Integration & Workflow Optimization (Weeks 5-8)
Integration of MyoFuse into your automated microscopy pipeline for batch processing of large image sets. Optimization of image acquisition and processing parameters for maximal throughput and accuracy. Training of personnel on the MyoFuse interface and data interpretation.
Phase 4: Scalable Deployment & Data Analysis (Ongoing)
Full deployment of MyoFuse for all skeletal muscle cell fusion studies. Leveraging the high-throughput capabilities to generate statistically robust datasets, accounting for sample heterogeneity. Continuous monitoring and refinement of the AI models as new data becomes available.
Ready to Transform Your Myoblast Fusion Research?
MyoFuse offers a robust, high-throughput, and unbiased solution for quantifying skeletal muscle cell fusion. Schedule a personalized strategy session to explore how our AI workflow can integrate seamlessly into your laboratory, saving valuable time and delivering unparalleled accuracy.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat